Abnormal Cystic Tumor in a Patient with Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: Evidence of a Precursor Lesion?
The hereditary leiomyomatosis and renal cell cancer (HLRCC) association is a rare syndrome caused by mutation of the Kreb’s cycle enzyme, fumarate hydratase (FH). It is characterized by unusually aggressive type 2 papillary renal cell histology. FH is responsible for catalyzing the conversion of fum...
Main Authors: | Benjamin T. Ristau, Sonal N. Kamat, Tatum V. Tarin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Case Reports in Urology |
Online Access: | http://dx.doi.org/10.1155/2015/303872 |
Similar Items
-
Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids
by: Pietro Bortoletto, et al.
Published: (2017-07-01) -
Hereditary leiomyomatosis and renal cell carcinoma
by: Schmidt LS, et al.
Published: (2014-06-01) -
Hereditary Leiomyomatosis and Renal Cell Cancer
by: Anders Würgler Hansen, et al.
Published: (2020-01-01) -
Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
by: Benjamin Chaucer, et al.
Published: (2018-01-01) -
A Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma
by: Sarah Mehrtens, et al.
Published: (2016-01-01)